Rapafusyn Pharmaceuticals is based in Baltimore. It has raised $44M in total funding. Latest round: Series A.
Rapafusyn Pharmaceuticals is based in Baltimore. Rapafusyn Pharmaceuticals has raised $44M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Rapafusyn Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include BioTrack Capital, Yonjin Capital, 3E Bioventures Capital, Proxima Ventures Ltd., Lapam Capital. 5 distinct backers are named across the disclosed rounds.
We update the Rapafusyn Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Baltimore and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026